Clinical Trial Update: A Study of Verutex (Fusidic Acid), Eritex (Erythromycin) and Fisiogel in the Management of Tarceva-Associated Rash. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating fusidic acid (Verutex), erythromycin (Eritex), and Fisiogel for management of Tarceva-associated rash in non-small cell lung cancer; re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Eritex (erythromycin)
• Fisiogel
• Verutex (fusidic acid)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Non-Small Cell Lung Cancer | Phase 3 | Status: COMPLETED | Results posted: 2015-01-15